UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 343

Sortiert nach

Proceedings of the Summer School in Logic Leeds, 1967: N.A.T.O. Advanced Study Institute Meeting of the Association for Symbolic Logic

1968

Link zum Volltext

Verfügbarkeit prüfen

Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013

Antimicrobial agents and chemotherapy, 2015-06, Vol.59 (6), p.3606-3610

2015

Link zum Volltext

Verfügbarkeit prüfen

Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections - SMART United States 2018-2019

BMC microbiology, 2021-03, Vol.21 (1), p.74-74, Article 74

2021

Link zum Volltext

Verfügbarkeit prüfen

Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland—SMART 2017–2020

European journal of clinical microbiology & infectious diseases, 2023-03, Vol.42 (3), p.365-370

2023

Link zum Volltext

Verfügbarkeit prüfen

Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa – Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020

International journal of infectious diseases, 2022-12, Vol.125, p.250-257

2022

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015–2017

Journal of global antimicrobial resistance., 2020-06, Vol.21, p.223-228

2020

Link zum Volltext

Verfügbarkeit prüfen

Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013–2015

The Brazilian journal of infectious diseases, 2017-05, Vol.21 (3), p.343-348

2017

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018‒2020

The Brazilian journal of infectious diseases, 2023-05, Vol.27 (3), p.102775-102775, Article 102775

2023

Link zum Volltext

Verfügbarkeit prüfen

The decidua of preeclamptic-like BPH/5 mice exhibits an exaggerated inflammatory response during early pregnancy

Journal of reproductive immunology, 2017-04, Vol.120, p.27-33

2017

Link zum Volltext

Verfügbarkeit prüfen

Activity of ceftolozane–tazobactam and comparators against Pseudomonas aeruginosa from patients in different risk strata – SMART United States 2016–2017

Journal of global antimicrobial resistance., 2020-03, Vol.20, p.209-213

2020

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017

Antimicrobial agents and chemotherapy, 2020-02, Vol.64 (3)

2020

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of ceftolozane/tazobactam against Gram‐negative isolates collected from ICU patients with lower respiratory tract infections in seven Asian countries—SMART 2017–2019

Journal of global antimicrobial resistance., 2022-06, Vol.29, p.527-533

2022

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes—Study for Monitoring Antimicrobial Resistance Trends, United States 2015–2017

Clinical infectious diseases, 2021-06, Vol.72 (12), p.2112-2120

2021

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program)

Antimicrobial agents and chemotherapy, 2017-06, Vol.61 (6)

2017

Link zum Volltext

Verfügbarkeit prüfen

Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii

International journal of antimicrobial agents, 2016-04, Vol.47 (4), p.317-323

2016

Link zum Volltext

Verfügbarkeit prüfen

Carbapenem resistance among Gram-negative isolates collected from patients in ICU and non-ICU hospital wards in Hong Kong: SMART 2017–2020

Journal of global antimicrobial resistance., 2023-06, Vol.33, p.260-266

2023

Link zum Volltext

Verfügbarkeit prüfen

Proceedings of the Summer School in Logik, Leeds 1967

Löb, Martin H

1, 2006

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014

Journal of clinical microbiology, 2017-06, Vol.55 (6), p.1638-1649

2017

Link zum Volltext

Verfügbarkeit prüfen

Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014

Diagnostic microbiology and infectious disease, 2016-08, Vol.85 (4), p.459-465

2016

Link zum Volltext

Verfügbarkeit prüfen

In vitro activity of imipenem-relebactam against resistant phenotypes of Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples - SMART Surveillance Europe 2015-2017

Journal of medical microbiology, 2020-02, Vol.69 (2), p.207-217

2020

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of ESBL non-CRE Escherichia coli and Klebsiella pneumoniae among clinical isolates collected by the SMART global surveillance programme from 2015 to 2019

International journal of antimicrobial agents, 2022-03, Vol.59 (3), p.106535-106535, Article 106535

2022

Link zum Volltext

Verfügbarkeit prüfen

Activity of imipenem/relebactam against MDR Pseudomonas aeruginosa in Europe: SMART 2015-17

Journal of antimicrobial chemotherapy, 2019-08, Vol.74 (8), p.2284-2288

2019

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Imipenem-Relebactam against Clinical Isolates of Gram-Negative Bacilli Isolated in Hospital Laboratories in the United States as Part of the SMART 2016 Program

Antimicrobial agents and chemotherapy, 2018-07, Vol.62 (7)

2018

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020

Antimicrobial agents and chemotherapy, 2022-05, Vol.66 (5), p.e0018922-e0018922

2022

Link zum Volltext

Verfügbarkeit prüfen

In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017

Antimicrobial agents and chemotherapy, 2020-02, Vol.64 (3)

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 343

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(236)
Mit Volltextzugriff
(290)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Humans
(105)
Life Sciences & Biomedicine
(101)
Female
(51)
Male
(49)
Infectious Diseases
(38)
Adult
(35)
Microbiology
(35)
Technology
(32)
Middle Aged
(30)
Smart
(29)
Pharmacology & Pharmacy
(26)
Biological And Medical Sciences
(25)
Surveillance
(24)
Adolescent
(22)
Aged
(22)
Medical Sciences
(22)
Anti-Bacterial Agents - Pharmacology
(20)
Physical Sciences
(20)
Engineering
(19)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Proceedings of the Summer School in Logic Leeds, 1967: N.A.T.O. Advanced Study Institute Meeting of the Association for Symbolic Logic

Trends in susceptibility of Escherichia coli from intra-abdominal infections to ertapenem and comparators in the United States according to data from the SMART program, 2009 to 2013

Activity of ceftolozane/tazobactam against Gram-negative isolates from patients with lower respiratory tract infections - SMART United States 2018-2019

Activity of ceftolozane/tazobactam and imipenem/relebactam against clinical gram-negative isolates from Czech Republic, Hungary, and Poland—SMART 2017–2020

Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa – Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020

In vitro activity of imipenem/relebactam against Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples: SMART Surveillance United States 2015–2017

Resistance among Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Latin American countries: SMART 2013–2015

In vitro activity of imipenem/relebactam against non-Morganellaceae Enterobacterales and Pseudomonas aeruginosa in Latin America: SMART 2018‒2020

The decidua of preeclamptic-like BPH/5 mice exhibits an exaggerated inflammatory response during early pregnancy

Activity of ceftolozane–tazobactam and comparators against Pseudomonas aeruginosa from patients in different risk strata – SMART United States 2016–2017

In Vitro Activity of Eravacycline against Gram-Negative Bacilli Isolated in Clinical Laboratories Worldwide from 2013 to 2017

In vitro activity of ceftolozane/tazobactam against Gram‐negative isolates collected from ICU patients with lower respiratory tract infections in seven Asian countries—SMART 2017–2019

In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes—Study for Monitoring Antimicrobial Resistance Trends, United States 2015–2017

In Vitro Activity of Imipenem-Relebactam against Gram-Negative ESKAPE Pathogens Isolated by Clinical Laboratories in the United States in 2015 (Results from the SMART Global Surveillance Program)

Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii

Carbapenem resistance among Gram-negative isolates collected from patients in ICU and non-ICU hospital wards in Hong Kong: SMART 2017–2020

Proceedings of the Summer School in Logik, Leeds 1967

In Vitro Activity of Imipenem against Carbapenemase-Positive Enterobacteriaceae Isolates Collected by the SMART Global Surveillance Program from 2008 to 2014

Susceptibility patterns and ESBL rates of Escherichia coli from urinary tract infections in Canada and the United States, SMART 2010–2014

In vitro activity of imipenem-relebactam against resistant phenotypes of Enterobacteriaceae and Pseudomonas aeruginosa isolated from intraabdominal and urinary tract infection samples - SMART Surveillance Europe 2015-2017

Prevalence of ESBL non-CRE Escherichia coli and Klebsiella pneumoniae among clinical isolates collected by the SMART global surveillance programme from 2015 to 2019

Activity of imipenem/relebactam against MDR Pseudomonas aeruginosa in Europe: SMART 2015-17

In Vitro Activity of Imipenem-Relebactam against Clinical Isolates of Gram-Negative Bacilli Isolated in Hospital Laboratories in the United States as Part of the SMART 2016 Program

In Vitro Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020

In Vitro Activity of Eravacycline against Gram-Positive Bacteria Isolated in Clinical Laboratories Worldwide from 2013 to 2017

Suchergebnisse filtern